Goal of world market leader is not pie in the sky, founder says.
Tim Hunter Mon, 10 Sep 2018
Tauranga biotech company Honeylab is seeking further investment of up to $6 million as it prepares to commercialise two of its natural pharmaceutical products.
Nick Sandlant of Northington Partners, which is handling the capital raise, says the company’s preference is to bring in one or two
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
